Advertisement

Topics

Latest "Novelogics Biotechnology Centre Drug Research Development CDRD" News Stories

05:35 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Novelogics Biotechnology Centre Drug Research Development CDRD" found in our extensive news archives from over 250 global news sources.

More Information about Novelogics Biotechnology Centre Drug Research Development CDRD on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Novelogics Biotechnology Centre Drug Research Development CDRD for you to read. Along with our medical data and news we also list Novelogics Biotechnology Centre Drug Research Development CDRD Clinical Trials, which are updated daily. BioPortfolio also has a large database of Novelogics Biotechnology Centre Drug Research Development CDRD Companies for you to search.

Showing "Novelogics Biotechnology Centre Drug Research Development CDRD" News Articles 1–25 of 49,000+

Extremely Relevant

CDRD Appoints Didier Leconte to Its Board of Directors

CDRD –The Centre for Drug Research and Development, Canada’s national life sciences venture, is pleased to announce the appointment of Mr. Didier Leconte as a new Director of the organization. Mr. Leconte is Vice-President, Investments - Life Sciences with the Fonds de solidarité FTQ, which he first joined in 2012. With net assets of ove...


World Sepsis Day - Sepset Biosciences Inc. is Raising Awareness about One of the Most Prevalent and Deadly, Yet Misdiagnosed, Medical Conditions

Sepsis is the body’s over active and toxic response to an infection that causes hospitalization of more than 18 million people around the world every year, including 30,000 Canadians Declared a Global Health Priority by the World Health Organization in 2017 80% of sepsis deaths in hospitals could be prevented ...

CDRD to be Presented with the BIOTECanada Gold Leaf Ecosystem Builder Award Tonight in Canada’s Capital

CDRD, The Centre for Drug Research and Development will be honoured with the 2018 BIOTECanada Gold Leaf Ecosystem Builder Award at a special Global Biotech Week event tonight in Ottawa. The award recognizes CDRD’s contributions and impact as Canada’s national life sciences venture, bringing together national and international partners to be a ...


Catching the Future of Life Sciences and the Opportunities for Canada

In celebration of Global Biotech Week, CDRD and BIOTECanada invite you to a thought-provoking evening to experience changes in life sciences and biotechnology that are unfolding today. Join futurist Juan Enriquez, noted author (As the Future Catches You), Harvard professor, biotechnology entrepreneur, and investor who will be joined by Dr. Kym Boy...

CDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial

CDRD, Canada’s national life sciences venture, is pleased to announce an increased commitment to Sitka Biopharma with a $1.2M investment. This new investment will enable Sitka and its partner Cancer Research UK (CRUK) to accelerate critical development activities and rapidly enter clinical trials of STK-01, Sitka’s lead product for the treatment of bla...

Relevant

Scottish government invests £11m into Glasgow biotechnology centre

The Scottish government is investing £11 million into the Glasgow-based Industrial Biotechnology Innovation Centre (IBioIC), an innovation centre which facilitates collaboration between the biotechnology industry and academia. read more

Researchers discovered new immune response regulators

(University of Turku) The research groups of Academy Professor Riitta Lahesmaa and Research Director Laura Elo from Turku Centre for Biotechnology have discovered new proteins that regulate T cells in the human immune system. Some of these proteins can provide possible new targets for drug development in treating immune-mediated diseases.

Cocrystal Pharma to study hepatitis C drug in Hong Kong

US-based biotechnology firm Cocrystal Pharma has signed a clinical trial agreement with Humanity & Health Research Centre in Hong Kong...Read More... The post Cocrystal Pharma to study hepatitis C drug in Hong Kong appeared first on Drug Development Technology.

Lonza opens collaborative innovation centre in Haifa, Israel

New centre will be a hub to identify and accelerate fresh solutions to rethink drug development and manufacturing

Sitka Biopharma Announces New Investment from Global Health Sciences Fund

Sitka Biopharma is pleased to announce that Quark Venture Inc. and GF Securities, through their Global Health Sciences Fund (GHS), has invested $1.9M into Sitka – financing that will enable the company to complete critical GLP toxicology studies and GMP manufacture of clinical drug product. This in turn will allow Sitka and partner Cancer Research UK (CR...

AstraZeneca partners up with CRUK for new UK cancer drug discovery facility

AstraZeneca is to team up with Cancer Research UK to build a new centre of excellence for accelerating the discovery and development of new cancer drugs, leveraging genetic screening, cancer modelling, big data processes and tools such as CRISPR to better understand tumour disease and resistance mechanisms and inform more effective drug targeting. Located in the Milner Therapeutics Institute at th...

Cutting-edge electron microscope revealed at opening of new £5m structural biology centre

The University of Glasgow has opened an innovative new structural biology centre, home to a cutting-edge electron microscope – the first of its kind in Scotland – which will be used to image biological molecules at the atomic level. The technology will be used to support vital research into diseases posing the greatest threat to human and animal health, providing greater capabilities i...

Centre for Drug Research and Development Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryCentre for Drug Research and Development CDRD is a drug development and commercialization center that provides scientific infrastructure to transform discoveries into innovative therapeutic products and improved health outcomes. The center's drug development platform includes target validation, screening, drug delivery, medicinal chemistry, pharmacology and toxicology, biologics and externa...

Centre for Drug Research and Development Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryCentre for Drug Research and Development CDRD is a drug development and commercialization center that provides scientific infrastructure to transform discoveries into innovative therapeutic products and improved health outcomes. The center's drug development platform includes target validation, screening, drug delivery, medicinal chemistry, pharmacology and toxicology, biologics and externa...

Cancer Research and AstraZeneca launch genomics centre

Cancer Research UK and AstraZeneca have announced that they are opening a new centre in Cambridge, UK, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.

New alliance strives to advance human-based drug evaluation

Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS) at the University of Liverpool have announced plans to work together on the development of next generation human cell models to advance human based drug discovery.

Canadian Biotech Industry Recognizes Top Performers During Global Biotech Week

BIOTECanada is pleased to announce the 2018 winners of the Gold Leaf Awards which annually highlight innovation and entrepreneurship within the Canadian biotechnology industry. This national celebration of the Canadian industry represents an outstanding collection of companies and individuals who have helped lead the industry throughout 2018. “T...

World-class scientists to seek therapies and cures for dementia in new £20m Cardiff research centre

A new £20m research centre aimed at finding effective treatments for dementia will be officially opened at Cardiff University today by Health Secretary Vaughan Gething. More than 70 scientists from around the world have been recruited to the centre with the aim of expanding the group to 100 in the near future. The Cardiff centre […] The post World-class scientists to seek therapies and cure...

BioIVT publishes new research on the mechanisms underlying the C-DILI assay

(Rana Healthcare Solutions LLC) BioIVT, a leading provider of research models and services for drug development, today announced its research into the mechanisms involved in cholestatic drug-induced liver injury (DILI) has been published in Applied In Vitro Toxicology. DILI is one of the primary causes of drug development failures. As a result, sponsors endeavor to identify new drug candidates wit...

Researchers discover new disease with 'Bubble Boy' roots

(McGill University Health Centre) A team from the Research Institute of the McGill University Health Centre (RI-MUHC) led by Dr. Donald Vinh, the RI's so-called "Dr. House" because of his research into rare diseases, has discovered a new human disease and the gene responsible for it, paving the way for the proper diagnosis of patients globally and the development of new therapies. Their findings a...

€13.6m SFI Research Centre for neurological diseases launched by Minister Humphreys

(RCSI) FutureNeuro, a €13.6 million SFI Research Centre has been launched at RCSI, Dublin today. The Centre aims to translate breakthroughs in understanding of brain structure and function to transform the patient journey for people with neurological diseases

Cancer Research UK and AstraZeneca launch world class functional genomics centre

Press release Cancer Research UK and AstraZeneca have announced today that they are opening a new centre in the UK, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.  “This new

Drug development research agreement leverages simulation platform

Drug development advisory firm Rosa & Co. enters research agreement with Chugai pharmaceutical to provide access to PhysioPD research services for translational biology.

Another Medical cold case cracked by the MUHC's 'Dr. House'

(McGill University Health Centre) A team from the Research Institute of the McGill University Health Centre (RI-MUHC) led by Dr. Donald Vinh, the RI's so-called "Dr. House" because of his research into rare diseases, has discovered a new human disease and the gene responsible for it, paving the way for the proper diagnosis of patients globally and the development of new therapies. Their findings a...

Cancer Research UK and AstraZeneca launch functional genomics centre

The centre will be a dedicated resource for AstraZeneca and Cancer Research UK s academics and alliance partners working at all stages of translational research


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks